Fibrogen Stock Total Asset
| FGEN Stock | MXN 7.94 0.89 12.62% |
FibroGen fundamentals help investors to digest information that contributes to FibroGen's financial success or failures. It also enables traders to predict the movement of FibroGen Stock. The fundamental analysis module provides a way to measure FibroGen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to FibroGen stock.
FibroGen |
FibroGen Company Total Asset Analysis
FibroGen's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current FibroGen Total Asset | 773.82 M |
Most of FibroGen's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, FibroGen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
Based on the latest financial disclosure, FibroGen has a Total Asset of 773.82 M. This is 89.71% lower than that of the Healthcare sector and 60.84% lower than that of the Biotechnology industry. The total asset for all Mexico stocks is 97.37% higher than that of the company.
FibroGen Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses FibroGen's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of FibroGen could also be used in its relative valuation, which is a method of valuing FibroGen by comparing valuation metrics of similar companies.FibroGen is currently under evaluation in total asset category among its peers.
FibroGen Fundamentals
| Return On Equity | -1.85 | |||
| Return On Asset | -0.27 | |||
| Profit Margin | (2.94) % | |||
| Operating Margin | (2.52) % | |||
| Current Valuation | 21.87 B | |||
| Shares Outstanding | 93.96 M | |||
| Shares Owned By Insiders | 7.82 % | |||
| Shares Owned By Institutions | 78.80 % | |||
| Price To Book | 54.45 X | |||
| Price To Sales | 231.63 X | |||
| Revenue | 235.31 M | |||
| Gross Profit | (104.61 M) | |||
| EBITDA | (288.53 M) | |||
| Net Income | (290.02 M) | |||
| Cash And Equivalents | 565.4 M | |||
| Cash Per Share | 6.56 X | |||
| Total Debt | 77.14 M | |||
| Debt To Equity | 15.10 % | |||
| Current Ratio | 6.16 X | |||
| Book Value Per Share | 0.28 X | |||
| Cash Flow From Operations | (82.23 M) | |||
| Earnings Per Share | (62.14) X | |||
| Number Of Employees | 566 | |||
| Beta | 0.85 | |||
| Market Capitalization | 43.36 B | |||
| Total Asset | 773.82 M | |||
| Net Asset | 773.82 M |
About FibroGen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze FibroGen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of FibroGen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of FibroGen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for FibroGen Stock Analysis
When running FibroGen's price analysis, check to measure FibroGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FibroGen is operating at the current time. Most of FibroGen's value examination focuses on studying past and present price action to predict the probability of FibroGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FibroGen's price. Additionally, you may evaluate how the addition of FibroGen to your portfolios can decrease your overall portfolio volatility.